| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |